Position in PGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,438,947
+$1,783,804 QoQ
Shares Held
778,763
+13.5% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
0
PutValue
$1,576,920
PutShares
154,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. PGEN ranks #158 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in PGEN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,438,947 | 778,763 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,655,143 | 686,084 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,726,167 | 891,428 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,074,685 | 630,604 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $506,079 | 356,395 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $763,336 | 512,307 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $471,787 | 421,240 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $94,546 | 99,524 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $140,685 | 89,042 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $246,375 | 169,915 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $287,504 | 214,556 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $56,403 | 39,721 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $140,351 | 122,045 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $99,427 | 93,800 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $66,752 | 43,917 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $99,783 | 47,068 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $47,820 | 35,687 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $83,266 | 39,463 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,858,037 | 500,819 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,422,072 | 284,985 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $737,307 | 113,084 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,822,190 | 264,469 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,576,920 | 154,600 | Put | Defined | 2021-02-11 | |
| 2020-12-31 | $1,148,254 | 112,574 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $521,174 | 148,907 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $541,100 | 154,600 | Put | Defined | 2020-11-12 | |
| 2020-06-30 | $671,688 | 134,607 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $431,150 | 126,809 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||